ORPHA:420485
Cranio-cervical dystonia with laryngeal and upper-limb involvement
Also known as: DYT24 · Dystonia 24
Publications
981
86.1th percentile
Trials
0
Interventional, condition-specific
Researchers
1,141
Distinct authors in sample
Gene link
ANO3
Strong
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Cranio-cervical dystonia with laryngeal and upper-limb involvement is a rare genetic, isolated dystonia characterized by a variable combination of cervical dystonia with tremor, blepharospasm, oromandibular and laryngeal dystonia. Dystonia progresses slowly and might spread to become segmental. Arm tremor and myoclonic jerks in the arms or neck have also been reported.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0014019
- OMIM:615034
- UMLS:C3554374
Additional Mondo synonyms (5)
ANO3 dystonic disorder · DYT-ANO3 · dystonia 24 · dystonia type 24 · dystonic disorder caused by mutation in ANO3
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.
- Gene identifiedPresent
Strong — ANO3
- LiteraturePresent
981 matched papers (734 in last 10 years) Source
- Phenotype characterisedPresent
15 HPO annotations (e.g. Vocal tremor; Hand tremor; Myoclonus) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (ANO3).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
15
Associated phenotypes · MONDO:0014019
- Vocal tremor
- Hand tremor
- Myoclonus
- Abnormality of the larynx
- Blepharospasm
Showing 5 of 15 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
981
981 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
981 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
734 in the last 10 years · high confidence · 86.1th percentile (publications denominator)
Phrase hits: 261 · MeSH hits: 0
Who's working on it?
1,141
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Klein C8 papers · 2025
Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Papers in Europe PMC - 02Bhatia KP7 papers · 2025
Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK.
Papers in Europe PMC - 03Jinnah HA5 papers · 2025
Departments of Neurology, Human Genetics and Pediatrics, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Papers in Europe PMC - 04Ozelius LJ5 papers · 2021
Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
Papers in Europe PMC - 05Pandey S5 papers · 2025
Maulana Azad Medical College, and Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India.
Papers in Europe PMC - 06Albanese A4 papers · 2026
Department of Neurology, IRCCS Neurological Institute C. Mondino, Pavia, Italy.
Papers in Europe PMC - 07Erro R4 papers · 2025
Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Via Allende 43, 84081, Baronissi, SA, Italy. rerro@unisa.it.
Papers in Europe PMC - 08Hallett M4 papers · 2025
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Papers in Europe PMC - 09Lang AE4 papers · 2025
Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Papers in Europe PMC - 10Lohmann K4 papers · 2023
Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 21 · after dedupe 21 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 21 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (21)
- isrctn·ISRCTN11389213·Recruiting·How botulinum toxin treatment affects people with involuntary neck movements (cervical dystonia)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10664670·No longer recruiting·Investigating 4’PPT for pantothenate kinase associated neurodegeneration (PKAN)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11005905·No longer recruiting·Functional electrical stimulation (FES) in cerebral palsy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN63413322·No longer recruiting·Investigating the effects of nimodipine on spinal reflex measures in humans
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN85338453·No longer recruiting·A study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of selnofast in participants with early idiopathic Parkinson's disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN42991002·No longer recruiting·Using brain signals to control functional electrical stimulation during the intention to move a weak arm after a stroke
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14984258·No longer recruiting·A study to evaluate the safety, tolerability, processing by the body and mechanism of action of multiple doses of ralmitaront with a single dose of risperidone administered to healthy participants
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14399966·No longer recruiting·Esophageal motility disorders and gastroesophageal reflux in ventilated critically ill patients with different feeding tolerance: effect of prokinetics
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN51601294·Suspended·Finding brain signals that might guide the delivery of deep brain stimulation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN69044459·No longer recruiting·Exercise therapy intervention for children and young adults with cerebral palsy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN46828292·No longer recruiting·Treatment of complex regional pain syndrome (CRPS) with sensory-motor adaptation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36604066·No longer recruiting·Neuroimaging the effects of modafinil in healthy volunteers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84681422·No longer recruiting·Effects of Botulinum injections on the development of arm and hand function in children with unilateral spastic cerebral palsy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66900787·No longer recruiting·Neuroimaging effects of a single dose of modafinil on brain activation in patients with schizophrenia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN06886935·No longer recruiting·Cluster randomised trial of an intervention to promote implementation of clinical guidance on the management of suspected encephalitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36655259·No longer recruiting·Epidural spinal cord electrical stimulation frequency study in a group of patients with complex regional pain syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN58484608·No longer recruiting·Constraint induced movement therapy: A randomised controlled Trial in Children with Hemiplegic cerebral palsy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN51084195·No longer recruiting·Does the use of gait analysis for decision making, improve outcomes of surgery for children with cerebral palsy?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN97049967·No longer recruiting·Phase 3 long-term safety, tolerability and effectiveness of lurasidone in subjects with schizophrenia or schizoaffective disorder
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN43633981·No longer recruiting·Intrathecal Baclofen Infusion for Reflex sympathetic Dystrophy related dystonia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN75413193·No longer recruiting·Double-blind randomised placebo-controlled cross-over study to investigate the safety and effectiveness of intrathecal glycine on pain and dystonia in Complex Regional Pain Syndrome type 1
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Cranio-cervical dystonia with laryngeal and upper-limb involvement — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Cranio-cervical dystonia with laryngeal and upper-limb involvement" OR "DYT24" OR "Dystonia 24" OR "ANO3 dystonic disorder" OR "DYT-ANO3" OR "dystonia type 24" OR "dystonic disorder caused by mutation in ANO3") OR ("ANO3" OR "ANO3 syndrome" OR "ANO3-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Cranio-cervical dystonia with laryngeal and upper-limb involvement" OR "DYT24" OR "Dystonia 24" OR "ANO3 dystonic disorder" OR "DYT-ANO3" OR "dystonia type 24" OR "dystonic disorder caused by mutation in ANO3"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T15:47:08.531Z
